Continuum Health Ventures

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Immunis is a private biotechnology company focused on addressing age and disease-related immune decline through innovative stem cell-derived therapies. The company specializes in utilizing human stem cells to create specific populations of cells that secrete therapeutic factors. This approach aims to enable healthcare professionals to enhance immune system development, modulation, and overall health in patients. By harnessing the potential of stem cell technology, Immunis seeks to offer novel treatment options that can improve immune function and combat the effects of aging and various diseases.

Developer of a secure SaaS collaboration platform for creating secure data access to support impactful algorithm validation and development. The platform ensures data security through end-to-end encryption, uses primary data from the source, eliminates risks of data exfiltration and IP interrogation, and acts as a matchmaker between data stewards and algorithm developers.

Immunis is a private biotechnology company focused on addressing age and disease-related immune decline through innovative stem cell-derived therapies. The company specializes in utilizing human stem cells to create specific populations of cells that secrete therapeutic factors. This approach aims to enable healthcare professionals to enhance immune system development, modulation, and overall health in patients. By harnessing the potential of stem cell technology, Immunis seeks to offer novel treatment options that can improve immune function and combat the effects of aging and various diseases.

Enara Health is a digital health platform that offers personalized weight loss programs. It combines medical expertise from professionals like doctors and dietitians with proprietary algorithms, considering factors such as genetics, blood work, medical history, and weight history to create tailored nutrition, exercise, and medication plans.

Sanctuary AI, founded in January 2018 and based in Vancouver, Canada, is focused on developing synthetic humans, referred to as "synths." The company's mission is to create robots that are indistinguishable from humans in physical appearance, cognitive abilities, and emotional responses. In addition to advancing cutting-edge technology, Sanctuary AI is committed to addressing the ethical implications associated with the creation of human-like machines.